» Articles » PMID: 33219105

Characteristics of Germline Mutations in Korean Patients with Pheochromocytoma/paraganglioma

Overview
Journal J Med Genet
Specialty Genetics
Date 2020 Nov 21
PMID 33219105
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pheochromocytomas and paragangliomas (PPGLs) are catecholamine-producing neuroendocrine tumours. PPGLs are a rare but important cause of secondary hypertension owing to their high morbidity and mortality. Patients with PPGL exhibit an increased prevalence of mutations in one of the PPGL susceptibility genes according to previous studies. We aimed to investigate the characteristics of germline mutations in the largest number of Korean patients with PPGL.

Methods: In this study, 161 patients with PPGL were evaluated. Phenotype data, including biochemical, pathological and anatomical imaging results, were collected. Germline mutations in 10 PPGL-related genes were tested by targeted next-generation sequencing (NGS), Sanger sequencing and multiplex ligation-dependent probe amplification.

Results: Approximately 21% of apparently sporadic PPGLs harboured germline mutations of the PPGL-related genes. The mutation carriers were younger at the first diagnosis and had more bilateral (28.6% vs 4.0%, p<0.001) and multifocal (11.4% vs 1.6%, p=0.027) PPGLs, but showed no metastatic risk (17.1% vs 11.1%, p=0.504), than non-mutation carriers. Missense mutation of p.V111I was found in this cohort of Asian patients, which was associated with unilateral pheochromocytoma with dominantly epinephrine production.

Conclusion: This study covered the largest number of Korean patients with PPGL. To our knowledge, it is the first to compare results of targeted NGS panel with those of conventional sequencing methods in Asia. We demonstrated that the variant type, as well as the mutated gene, may determine the phenotype and prognosis of PPGLs.

Citing Articles

Nonstop mutations cause loss of renal tumor suppressor proteins and and affect multiple stages of protein translation.

Pal J, Riester M, Ganner A, Ghosh A, Dhamija S, Mookherjee D Sci Adv. 2025; 11(7):eadr6375.

PMID: 39937911 PMC: 11817944. DOI: 10.1126/sciadv.adr6375.


Germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review.

Jo K, Lee J, Yoo J, Kim H, Kim E, Han J Ann Lab Med. 2024; 44(6):591-597.

PMID: 39069753 PMC: 11375186. DOI: 10.3343/alm.2023.0376.


International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Abib S, Chui C, Cox S, Abdelhafeez A, Fernandez-Pineda I, Elgendy A Ecancermedicalscience. 2022; 16:1356.

PMID: 35510137 PMC: 9023308. DOI: 10.3332/ecancer.2022.1356.


Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma.

Pipitprapat W, Pattanaprateep O, Iemwimangsa N, Sensorn I, Panthan B, Jiaranai P Ann Med. 2021; 53(1):1244-1256.

PMID: 34309460 PMC: 8317928. DOI: 10.1080/07853890.2021.1956687.


Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force.

Ku E, Kim K, Kim J, Kim M, Ahn C, Lee K Endocrinol Metab (Seoul). 2021; 36(2):322-338.

PMID: 33820394 PMC: 8090459. DOI: 10.3803/EnM.2020.908.